Guided Therapeutics, Inc. (OTCBB: GTHP) utilizes its patented biophotonic technology for the development of a testing platform that uses light for the early detection of disease at the cellular level.  The company’s first planned product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, LuVida® demonstrated its ability to detect cervical cancer up to two years earlier than conventional modalities. Guided Therapeutics is also using the technology to develop a non-invasive test for Barrett’s Esophagus. For more information, visit the company’s website at www.guidedinc.com